RemodelingYersinia pseudotuberculosisto generate a highly immunogenic outer membrane vesicle vaccine against pneumonic plague
Open Access
- 11 March 2022
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (11)
Abstract
Significance: Yersinia pestis, the etiologic agent of plague, has been responsible for high mortality in several epidemics throughout human history. This plague bacillus has been used as a biological weapon during human history and is currently one of the deadliest biological threats. Currently, no licensed plague vaccines are available in the Western world. Since an array of immunogens are enclosed in outer membrane vesicles (OMVs), immune responses elicited by OMVs against a diverse range of antigens may reduce the likelihood of antigen circumvention. Therefore, self-adjuvanting OMVs from a remodeledYersinia pseudotuberculosisstrain as a type of plague vaccine could diversify prophylactic choices and solve current vaccine limitations.Keywords
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI148366)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R21AI139703 and R01AI125623)
This publication has 54 references indexed in Scilit:
- Early Host Cell Targets of Yersinia pestis during Primary Pneumonic PlaguePLOS Pathogens, 2013
- Discovery of a cardiolipin synthase utilizing phosphatidylethanolamine and phosphatidylglycerol as substratesProceedings of the National Academy of Sciences, 2012
- Humoral and Cellular Immune Responses to Yersinia pestis Infection in Long-Term Recovered Plague PatientsClinical and Vaccine Immunology, 2012
- A live attenuated strain of Yersinia pestis KIM as a vaccine against plagueVaccine, 2011
- IL-17 Contributes to Cell-Mediated Defense against Pulmonary Yersinia pestis InfectionThe Journal of Immunology, 2011
- Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challengeVaccine, 2010
- D27-pLpxL, an Avirulent Strain of Yersinia pestis , Primes T Cells That Protect against Pneumonic PlagueInfection and Immunity, 2009
- Immune defense against pneumonic plagueImmunological Reviews, 2008
- Lipopolysaccharide Analogs Improve Efficacy of Acellular Pertussis Vaccine and Reduce Type I Hypersensitivity in MiceClinical and Vaccine Immunology, 2007
- Multiple Antimicrobial Resistance in Plague: An Emerging Public Health RiskPLOS ONE, 2007